Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- A8606 PD 180970Summary: P210bcr/abl tyrosine kinase inhibitor
- A8607 PPY ATarget: Abl kinasesSummary: Abl kinases inhibitor
- A8620 AZD-34633 CitationTarget: ALK|Insulin-like growth factors (IGFs)Summary: ALK/IGF1R inhibitor
- A8661 MNSSummary: Inhibitor of Src/Syk tyrosine kinases
- A8683 NVP-BHG712Target: Eph Receptors|VEGFRSummary: EphB4 inhibitor,potent and selective
- A8684 ZM 306416Summary: VEGFR (Flt and KDR) inhibitor
- A8691 Flumatinib mesylateSummary: PDGRFβ inhibitor
- A8692 PF-431396Summary: Pyk2 and FAK inhibitor
- A8812 PD173955Target: Bcr-Abl|SrcSummary: Dual Src/Abl kinase inhibitor, ATP-competitive,
- B1305 SKLB1002Summary: VEGFR2 inhibitor,potent and ATP-competitve